Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Brown

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Nature and Science of Sleep|October 21, 2022
Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current InsightsDaniel P Cardinali, Gregory M Brown, Seithikurippu R Pandi-Perumal
Medical Hypotheses|March 3, 2021
Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatoninGregory M Brown, Ramanujam Karthikeyan, Seithikurippu R Pandi-Perumal, et al.
Journal of Psychiatry & Neuroscience : JPN|February 12, 2002
Low-dose dexamethasone challenge in women with atypical major depression: pilot studyRobert D Levitan, Franco J Vaccarino, Gregory M Brown, et al.
Journal of Circadian Rhythms|September 14, 2018
Are Type 2 Diabetes Mellitus and Depression Part of a Common Clock Genes Network?Ramanujam Karthikeyan, David Warren Spence, Gregory M Brown, et al.
Travel Medicine and Infectious Disease|February 25, 2009
Melatonin and its relevance to jet lagGregory M Brown, Seithikurippu R Pandi-Perumal, Ilya Trakht, et al.
Progress in Neurobiology|February 21, 2015
Melatonin and brain inflammagingRüdiger Hardeland, Daniel P Cardinali, Gregory M Brown, et al.
European Journal of Pharmacology|May 26, 2015
Some implications of melatonin use in chronopharmacology of insomniaDiego A Golombek, Seithikurippu R Pandi-Perumal, Gregory M Brown, et al.
Translational Psychiatry|June 3, 2021
Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disordersLindsay M Melhuish Beaupre, Gregory M Brown, Vanessa F Gonçalves, et al.
International Journal of Alzheimer'S Disease|January 4, 2011
Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic valueVenkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Pandi-Perumal, et al.
CNS & Neurological Disorders Drug Targets|April 10, 2012
Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disordersVenkatramanujam Srinivasan, Rahimah Zakaria, Zahiruddin Othaman, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Nature and Science of Sleep|October 21, 2022
Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current InsightsDaniel P Cardinali, Gregory M Brown, Seithikurippu R Pandi-Perumal
Medical Hypotheses|March 3, 2021
Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatoninGregory M Brown, Ramanujam Karthikeyan, Seithikurippu R Pandi-Perumal, et al.
Journal of Psychiatry & Neuroscience : JPN|February 12, 2002
Low-dose dexamethasone challenge in women with atypical major depression: pilot studyRobert D Levitan, Franco J Vaccarino, Gregory M Brown, et al.
Journal of Circadian Rhythms|September 14, 2018
Are Type 2 Diabetes Mellitus and Depression Part of a Common Clock Genes Network?Ramanujam Karthikeyan, David Warren Spence, Gregory M Brown, et al.
Travel Medicine and Infectious Disease|February 25, 2009
Melatonin and its relevance to jet lagGregory M Brown, Seithikurippu R Pandi-Perumal, Ilya Trakht, et al.
Progress in Neurobiology|February 21, 2015
Melatonin and brain inflammagingRüdiger Hardeland, Daniel P Cardinali, Gregory M Brown, et al.
European Journal of Pharmacology|May 26, 2015
Some implications of melatonin use in chronopharmacology of insomniaDiego A Golombek, Seithikurippu R Pandi-Perumal, Gregory M Brown, et al.
Translational Psychiatry|June 3, 2021
Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disordersLindsay M Melhuish Beaupre, Gregory M Brown, Vanessa F Gonçalves, et al.
International Journal of Alzheimer'S Disease|January 4, 2011
Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic valueVenkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Pandi-Perumal, et al.
CNS & Neurological Disorders Drug Targets|April 10, 2012
Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disordersVenkatramanujam Srinivasan, Rahimah Zakaria, Zahiruddin Othaman, et al.
Pageof 6